ARGX
$308.00
Argenx Se ADR
($10.01)
(3.15%)
ARGX
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($4.48)
Revenue:  $22.00 Mil
Thursday
Oct 28
1:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ARGX reports earnings?
Beat
Meet
Miss

Where is ARGX's stock price going from here?
Up
Flat
Down
Stock chart of ARGX
Analysts
Summary of analysts' recommendations for ARGX
Score
Grade
Pivots
Resistance
$319.69
$316.85
$312.42

$309.58

Support
$305.15
$302.31
$297.88
Tweet
Growth
Description
argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.